GO ID |
Ontology |
GO Term |
Term Definition |
Proteins |
GO:0045838
|
BP
|
positive regulation of membrane potential
|
Any process that activates or increases the frequency, rate or extent of establishment or extent of a membrane potential, the electric potential existing across any membrane arising from charges in the membrane itself and from the charges present in the media on either side of the membrane.
|
GLRX,
ANK3
|
GO:0045839
|
BP
|
negative regulation of mitotic nuclear division
|
Any process that stops, prevents or reduces the rate or extent of mitosis. Mitosis is the division of the eukaryotic cell nucleus to produce two daughter nuclei that, usually, contain the identical chromosome complement to their mother.
|
CHEK1,
NME6,
BMP4,
AURKAIP1
|
GO:0045840
|
BP
|
positive regulation of mitotic nuclear division
|
Any process that activates or increases the frequency, rate or extent of mitosis.
|
EREG,
AURKA,
LRP5,
PDGFB,
TGFA,
INS,
IGF2,
IL1A,
IL1B,
IGF1,
EDN1,
INSR,
PDGFRB,
CD28,
BTC,
PHIP,
NUSAP1,
RGCC,
SH2B1
|
GO:0045842
|
BP
|
positive regulation of mitotic metaphase/anaphase transition
|
Any process that activates or increases the frequency, rate or extent of the cell cycle process in which a cell progresses from metaphase to anaphase during mitosis, triggered by the activation of the anaphase promoting complex by Cdc20/Sleepy homolog which results in the degradation of Securin.
|
RB1,
CUL3,
ESPL1,
DLGAP5
|
GO:0045843
|
BP
|
negative regulation of striated muscle tissue development
|
Any process that stops, prevents, or reduces the frequency, rate or extent of striated muscle development.
|
SOX15,
BMP4,
SIRT2,
LUC7L
|
GO:0045844
|
BP
|
positive regulation of striated muscle tissue development
|
Any process that activates or increases the frequency, rate or extent of striated muscle development.
|
GJA1,
MKL2
|
GO:0045859
|
BP
|
regulation of protein kinase activity
|
Any process that modulates the frequency, rate or extent of protein kinase activity.
|
IKBKAP,
FGR,
CDK4,
RAC2,
CDC42,
TRPT1,
SMG8,
TTN,
GCN1,
ELP4,
TSPYL2,
ECT2,
ELP3,
KIDINS220,
FAF1
|
GO:0045860
|
BP
|
positive regulation of protein kinase activity
|
Any process that activates or increases the frequency, rate or extent of protein kinase activity.
|
CYR61,
EREG,
DAB1,
GCG,
TNF,
CD4,
RPLP1,
PTPRC,
ZP3,
CDC25B,
SDC4,
CDKN1A,
IQGAP1,
PRKAG1,
RAP1A,
VLDLR,
CDK5,
CENPE,
PTK2,
GAS6,
MMD,
CACUL1,
DUSP19,
ALS2,
SNX9
|
GO:0045861
|
BP
|
negative regulation of proteolysis
|
Any process that stops, prevents, or reduces the frequency, rate or extent of the hydrolysis of a peptide bond or bonds within a protein.
|
F2,
PLAT,
CST3,
CSTA,
KNG1,
INS,
CSTB,
SERPINE2,
IDE,
SERPINB3,
AKT1,
NR1H2,
CDK5,
CLN3,
DNAJC1,
HDAC6
|
GO:0045862
|
BP
|
positive regulation of proteolysis
|
Any process that activates or increases the frequency, rate or extent of the hydrolysis of a peptide bond or bonds within a protein.
|
OGT,
CAPN3,
PLK1,
IST1,
ASPH,
FADD,
CASP8,
HDAC2,
BAD,
CYFIP2,
PERP,
AURKAIP1,
CLN6,
BTRC
|
GO:0045869
|
BP
|
negative regulation of single stranded viral RNA replication via double stranded DNA intermediate
|
Any process that stops, prevents, or reduces the frequency, rate or extent of single stranded viral RNA replication via double stranded DNA intermediate.
|
HMGA2,
TRIM28,
INPP5K,
APOBEC3G
|
GO:0045870
|
BP
|
positive regulation of single stranded viral RNA replication via double stranded DNA intermediate
|
Any process that activates or increases the frequency, rate or extent of retroviral genome replication.
|
TOP2A
|
GO:0045875
|
BP
|
negative regulation of sister chromatid cohesion
|
Any process that stops, prevents, or reduces the frequency, rate or extent of sister chromatid cohesion.
|
ESPL1,
WAPL
|
GO:0045876
|
BP
|
positive regulation of sister chromatid cohesion
|
Any process that activates or increases the frequency, rate or extent of sister chromatid cohesion.
|
SFPQ
|
GO:0045879
|
BP
|
negative regulation of smoothened signaling pathway
|
Any process that stops, prevents, or reduces the frequency, rate or extent of smoothened signaling.
|
TULP3,
RB1,
SERPINE2,
GLI3,
PTCH1,
RUNX2,
KCTD11,
HHIP,
SALL3,
IFT122,
SUFU,
BTRC
|
GO:0045880
|
BP
|
positive regulation of smoothened signaling pathway
|
Any process that activates or increases the frequency, rate or extent of smoothened signaling.
|
SHOX2,
FGF9,
CTNNA1,
EVC,
CHSY1,
SFRP1,
DCDC2,
INTU
|
GO:0045892
|
BP
|
negative regulation of transcription, DNA-templated
|
Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription.
|
WWP2,
ARNTL,
FOXN3,
BHLHE40,
EREG,
BTAF1,
HDAC3,
BIRC5,
FOXP2,
PER1,
RBFOX2,
CBFA2T2,
KLF4,
ATP8B1,
KDM1A,
GREM1,
RAMP3,
DNAJB6,
ZNF253,
ZNF217,
PEX14,
GMNN,
RPS6KA5,
HEXIM1,
ZBTB7A,
PDGFB,
TGFB1,
TNF,
TP53,
JUN,
RB1,
ENO1,
GLI3,
THRA,
IRF1,
VDR,
BMP2,
BMP4,
XRCC5,
POU2F1,
FABP4,
GCFC2,
ZNF12,
ZNF24,
HMGA1,
CEBPB,
WT1,
NR1D1,
BCL3,
CAPN3,
ZP3,
SFPQ,
TNFSF4,
NR2F2,
MT3,
HMGB2,
CALR,
YWHAB,
CTNNB1,
PHB,
DDIT3,
ZNF93,
AHR,
PPARG,
ZEB1,
BRCA1,
ID1,
BCL6,
WNT5A,
ELK3,
NKX2-1,
CBX5,
CDKN1B,
NOTCH1,
ID4,
LIMS1,
SOX9,
GCLC,
CENPF,
PPM1F,
CEBPD,
CDKN1C,
ASCL1,
DAP,
SMARCA2,
SMARCA4,
NR0B1,
HMGA2,
ATXN1,
NR1H2,
FOXG1,
HDAC4,
CTBP2,
SOX8,
FOXL2,
UBE2I,
ELF3,
CBX1,
FOXK1,
ZBED6,
DAB2,
CDK5,
PURA,
MDM2,
E2F1,
SET,
NRG1,
ID2,
SP3,
ID3,
HHEX,
CREM,
PPARD,
RELA,
TLE1,
ZNF91,
ZBTB16,
RING1,
KHDRBS1,
FOXM1,
AES,
FOXO1,
ILF3,
STRN3,
KLF10,
CBX3,
TRIM28,
IKZF1,
SMAD4,
HDAC1,
C1D,
RUNX2,
GAS6,
HES1,
ARID5B,
NR1D2,
NONO,
PTPRK,
TWIST1,
SMAD2,
CCDC85B,
ADIPOQ,
EZH2,
CRY1,
IFI16,
ZNF423,
LRRFIP1,
GON4L,
PDCD4,
DEPDC1,
ZNF658,
NIPBL,
ZNF280D,
ATF7IP,
KCTD1,
BEND5,
ZBTB33,
ZNF280B,
PPARGC1B,
GATAD2A,
TMPRSS6,
MINA,
NOSTRIN,
SIRT2,
YAF2,
CCAR2,
SFRP1,
NKAP,
EID2,
ZBTB38,
SMARCC2,
ZFPM2,
PSPC1,
KAT6B,
HDAC2,
PROX1,
KAT6A,
GATA6,
PBXIP1,
HIC2,
PRMT6,
PRICKLE1,
PHF12,
TRIB3,
ATOH8,
RSF1,
SPEN,
SETDB2,
PFDN5,
MPHOSPH8,
PHB2,
MDFI,
CITED1,
CITED2,
MYBBP1A,
INPP5K,
LGR4,
FOXP3,
TRIM6,
ZNF350,
WWP1,
EPC1,
IKZF4,
FOXP1,
SUV39H2,
ZNF552,
SUDS3,
SMURF2,
PATZ1,
CHD8,
BRD7,
PLCB1,
HEYL,
TCF7L2,
KMT5A,
PRDM6,
RLIM,
BCLAF1,
RBAK,
ZNF224,
NDUFA13,
ZBTB4,
HDAC6,
DKK3,
KDM5B,
LIMD1,
MLX,
DACH1,
ZNF639,
HDAC9,
ZHX1,
YEATS2,
SNX6,
TIMELESS,
TRIM33,
PA2G4,
HDAC5,
ZNF148,
RASD1,
BTRC,
TSC22D4,
L3MBTL1,
LOXL2,
HES2,
HEY1,
ZNF706,
EID1
|
GO:0045893
|
BP
|
positive regulation of transcription, DNA-templated
|
Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
|
APBB1,
ARNTL,
FOXN3,
NR5A2,
ARID1A,
MSTN,
IRF6,
AXIN1,
TOX3,
TGFB1I1,
TBX1,
KLF4,
FOXO3,
MED14,
SMARCA5,
CREBL2,
EDF1,
TBL1X,
MITF,
FZD7,
LRP5,
SUPT3H,
TADA3,
LRP6,
KLF7,
SEC14L2,
BMP10,
YEATS4,
NFATC1,
BMP15,
BCL10,
AGT,
FOS,
MYC,
PDGFB,
TGFB1,
TNF,
IL1B,
COL1A1,
ESR1,
MYCN,
TP53,
IGF1,
IL6,
JUN,
INSR,
RB1,
NPM1,
INHBA,
FGF2,
GLI2,
GLI3,
MYBL1,
AR,
IRF1,
EGR2,
BMP2,
BMP4,
ETS1,
ETS2,
TCF4,
TCF3,
CREB1,
HMGA1,
IFNAR1,
TAL1,
ERCC2,
EGR1,
ATF4,
ELK1,
WT1,
NFKB1,
CCNA2,
NR1D1,
BCL3,
CAPN3,
HNF1A,
MDK,
ZP3,
FGF7,
IL10,
SP100,
NR2F2,
CDK2,
F2R,
NFYB,
MT3,
HMGB2,
ARNT,
SMARCA1,
MAPK1,
KDM5A,
OTX2,
FOXN2,
CKS2,
CTNNB1,
PHB,
RORA,
DDIT3,
AHR,
MAP2K2,
TGFBR1,
NUP62,
PPARG,
BRCA1,
STAT3,
WNT5A,
GATA4,
NKX2-1,
NOTCH1,
SOX9,
NRIP1,
PSEN1,
CDKN1C,
AGTR2,
LHX2,
CDK7,
SMARCA2,
SMARCA4,
BRCA2,
IRAK1,
NEK4,
MRPL12,
HMGA2,
BLM,
NR1H2,
DLX5,
HDAC4,
SOX8,
FOXL2,
CKS1B,
ELF3,
SMAD3,
FOXK1,
DAB2,
TFAM,
NDP,
E2F1,
RUNX1,
ID2,
SP3,
MAP2K1,
CREB5,
POU3F1,
PPARD,
RELA,
ACVR1,
YWHAH,
ZBTB16,
MEF2C,
PAX8,
SOX4,
PPARA,
FOXM1,
FOXO1,
ILF2,
ILF3,
FOXC1,
MLLT11,
ZBTB17,
NR1H3,
BAMBI,
TRIM28,
UBE2V1,
ILK,
NFATC2,
SMAD4,
PICALM,
HDAC1,
PTCH1,
RUNX3,
NCOA4,
RUNX2,
HNRNPD,
NPAT,
NFE2L1,
NR1D2,
ERBB4,
NCOA1,
SMAD2,
ZFHX3,
ZIC1,
HIF1A,
ZNF423,
HIVEP3,
RGMB,
PSRC1,
ATAD2,
SMARCD3,
ATF7IP,
KDM7A,
RNF111,
GPBP1,
CRLF3,
TP53INP2,
YAF2,
KMT2E,
SFRP1,
AFAP1L2,
BANP,
CTCFL,
SMARCC2,
SETD7,
CHURC1,
NAT14,
PHIP,
ARNTL2,
KAT6B,
ESR2,
HDAC2,
PROX1,
CREBBP,
KAT6A,
TAF15,
SMARCC1,
MED12,
TP53INP1,
MED30,
ATOH8,
RSF1,
KLF6,
SMAD5,
HNRNPAB,
NPAS2,
CITED1,
CITED2,
SOST,
INPP5K,
WAC,
NUP85,
LGR4,
NAA15,
TBL1XR1,
FOXP3,
NIF3L1,
EPC1,
HIPK2,
SMARCAD1,
SOX17,
ZNF287,
GPBP1L1,
CHD8,
ENY2,
BRD7,
MED4,
PLCB1,
MED17,
RRN3,
EHF,
PPARGC1A,
RNF14,
FZD4,
USP22,
MAPRE3,
RNF6,
BTRC,
MYRF,
THRAP3,
MED16,
NFE2L3,
KLF2,
WNT6,
NCOA3
|
GO:0045898
|
BP
|
regulation of RNA polymerase II transcriptional preinitiation complex assembly
|
Any process that modulates the frequency, rate or extent of RNA polymerase II transcriptional preinitiation complex assembly.
|
ATF7IP
|
GO:0045899
|
BP
|
positive regulation of RNA polymerase II transcriptional preinitiation complex assembly
|
Any process that activates or increases the frequency, rate or extent of RNA polymerase II transcriptional preinitiation complex assembly.
|
CREB1,
PSMC3,
PSMC2,
PSMC4,
PSMC1,
PSMC6,
CAND1
|
GO:0045900
|
BP
|
negative regulation of translational elongation
|
Any process that stops, prevents, or reduces the frequency, rate or extent of translational elongation.
|
SRP9
|
GO:0045901
|
BP
|
positive regulation of translational elongation
|
Any process that activates or increases the frequency, rate or extent of translational elongation.
|
EIF5A,
EIF5A2
|
GO:0045903
|
BP
|
positive regulation of translational fidelity
|
Any process that increases the ability of the translational apparatus to interpret the genetic code.
|
RPS9
|
GO:0045905
|
BP
|
positive regulation of translational termination
|
Any process that activates or increases the frequency, rate or extent of translational termination.
|
EIF5A,
EIF5A2
|
GO:0045906
|
BP
|
negative regulation of vasoconstriction
|
Any process that stops, prevents, or reduces the frequency, rate or extent of vasoconstriction.
|
ADM,
LEP,
BMPR2,
APLN
|
GO:0045907
|
BP
|
positive regulation of vasoconstriction
|
Any process that activates or increases the frequency, rate or extent of vasoconstriction.
|
EGFR,
FGA,
FGB,
FGG,
ICAM1,
GJA1,
ADRA1D,
PTAFR,
F2R,
AVPR2,
OXTR,
AKT1,
ADRA1A,
PTGS2,
HRH1,
ADRA1B,
GJA5,
CAV1,
TRPM4
|
GO:0045908
|
BP
|
negative regulation of vasodilation
|
Any process that stops, prevents, or reduces the frequency, rate or extent of vasodilation.
|
INS,
CRP,
HMGCR,
ADORA1
|
GO:0045909
|
BP
|
positive regulation of vasodilation
|
Any process that activates or increases the frequency, rate or extent of vasodilation.
|
EGFR,
AGT,
INS,
HMOX1,
GJA1,
PTAFR,
PTPRM,
NOS3,
ADM,
GJA5,
AGTR2,
F2RL1,
PPARD,
PTGDR,
GPER1,
SCPEP1,
APLN
|
GO:0045910
|
BP
|
negative regulation of DNA recombination
|
Any process that stops, prevents, or reduces the frequency, rate or extent of DNA recombination.
|
MSH3,
MSH2,
MSH6,
BLM
|
GO:0045916
|
BP
|
negative regulation of complement activation
|
Any process that stops, prevents, or reduces the frequency, rate or extent of complement activation.
|
CD55
|
GO:0045917
|
BP
|
positive regulation of complement activation
|
Any process that activates or increases the frequency, rate or extent of complement activation.
|
PHB
|
GO:0045918
|
BP
|
negative regulation of cytolysis
|
Any process that stops, prevents, or reduces the frequency, rate or extent of cytolysis.
|
PF4,
BAD
|
GO:0045919
|
BP
|
positive regulation of cytolysis
|
Any process that activates or increases the frequency, rate or extent of cytolysis.
|
GPLD1,
LILRB1
|
GO:0045920
|
BP
|
negative regulation of exocytosis
|
Any process that stops, prevents, or reduces the frequency, rate or extent of exocytosis.
|
ANXA1,
SNCA,
STXBP6
|
GO:0045921
|
BP
|
positive regulation of exocytosis
|
Any process that activates or increases the frequency, rate or extent of exocytosis.
|
RAB27B,
FGA,
FGB,
FGG,
CFTR,
RAB5A,
RAB9A,
RAB27A,
NCS1,
STXBP5,
EXPH5,
RAB2B,
SYTL4
|
GO:0045922
|
BP
|
negative regulation of fatty acid metabolic process
|
Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways involving fatty acids.
|
INS
|
GO:0045923
|
BP
|
positive regulation of fatty acid metabolic process
|
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving fatty acids.
|
ADIPOQ,
GHSR
|
GO:0045925
|
BP
|
positive regulation of female receptivity
|
Any process that activates or increases the receptiveness of a female to male advances.
|
THRA,
NCOA1
|
GO:0045926
|
BP
|
negative regulation of growth
|
Any process that stops, prevents or reduces the rate or extent of growth, the increase in size or mass of all or part of an organism.
|
MT2A,
MT1E,
MT1F,
MT1G,
IGFBP5,
MT1H,
MT1X,
HIF1A,
MT1M,
PNPT1
|
GO:0045927
|
BP
|
positive regulation of growth
|
Any process that activates or increases the rate or extent of growth, the increase in size or mass of all or part of an organism.
|
ZPR1,
PPM1F
|
GO:0045930
|
BP
|
negative regulation of mitotic cell cycle
|
Any process that stops, prevents or reduces the rate or extent of progression through the mitotic cell cycle.
|
BRINP1,
EGFR,
TGFB1,
TIMP2,
IL10,
CDKN1B,
GAS1,
SMAD3,
FOXC1,
DLG1,
MAD2L1,
HECA,
TRIM35
|
GO:0045931
|
BP
|
positive regulation of mitotic cell cycle
|
Any process that activates or increases the rate or extent of progression through the mitotic cell cycle.
|
USP2,
APP,
CDK1,
EIF4E,
ASNS,
CCNB1,
PRKCA,
TAL1,
CDC25B,
DUSP3,
BRCA2,
STAT5B,
MDM2,
PTPN11,
EIF4EBP1,
SHB,
PKN2,
SPHK1,
USP22,
POLDIP2
|
GO:0045932
|
BP
|
negative regulation of muscle contraction
|
Any process that stops, prevents, or reduces the frequency, rate or extent of muscle contraction.
|
TNNT1
|
GO:0045943
|
BP
|
positive regulation of transcription from RNA polymerase I promoter
|
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase I promoter.
|
PPP1R15A,
ERBB2,
UBTF,
ATF4
|
GO:0045944
|
BP
|
positive regulation of transcription from RNA polymerase II promoter
|
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
E2F8,
MED19,
HAX1,
TLR4,
APBB1,
SUPT5H,
WWP2,
ARNTL,
MEIS1,
NR5A2,
DDX3X,
CYR61,
NFIB,
ITGB1BP1,
TNFSF11,
BACH1,
CASK,
PPP1R12A,
SMAD7,
PLSCR1,
OGT,
SOX12,
HDAC3,
TLR3,
MAFG,
PER1,
RIPK2,
HOXA2,
TBX1,
CBFA2T2,
KLF4,
FOXO3,
LDB2,
TCF21,
TRIAP1,
RAD21,
MED14,
SOX15,
PARK2,
ZEB2,
KDM1A,
CCNT1,
GREM1,
CCNT2,
TLR2,
BRD4,
SHOX2,
TBL1X,
MITF,
LRP5,
MAF,
LRP6,
RPS6KA5,
MED6,
NFAT5,
ABLIM3,
TNKS,
NFATC1,
IL33,
EGFR,
FOS,
MYC,
TGFB1,
POMC,
CGA,
FSHB,
PTH,
TNF,
IL1A,
IL1B,
PF4,
ESR1,
RAF1,
NR3C1,
MYCN,
TP53,
IGF1,
APP,
SERPINE1,
IL6,
EDN1,
JUN,
RB1,
PGR,
ADRB2,
DCN,
PFN1,
INHBA,
MET,
NFIC,
FGF2,
HOXB5,
HMGB1,
WNT2,
PARP1,
H2AFZ,
UBC,
GLI2,
GLI3,
MYBL1,
MYBL2,
AR,
NR2F1,
CD28,
THRA,
IRF1,
EGR2,
TOP2A,
VDR,
ESRRA,
BMP2,
BMP4,
SKI,
HGF,
HCLS1,
DRD2,
ETS1,
LIF,
ETS2,
FOSL1,
FOSL2,
VEGFA,
TCF4,
TCF3,
CREB1,
EPCAM,
RHOQ,
HMGA1,
JUNB,
JUND,
TAL1,
CEBPB,
DDX5,
XBP1,
ERCC2,
ARF4,
EGR1,
ATF1,
ATF3,
ATF4,
ELK1,
TFEB,
WT1,
NFKB1,
BCL3,
IL11,
HNF1A,
S1PR1,
FGFR2,
BMP6,
IL10,
NME2,
GAL,
NR4A1,
ITGA6,
YY1,
LMO2,
HMGB2,
ACVR2A,
MAPK3,
ARNT,
PIK3R1,
HOXD10,
MZF1,
RXRB,
RBL1,
HOXA10,
AKT1,
OTX2,
GTF2H1,
CTNNB1,
RORA,
DDIT3,
SOX6,
AHR,
BMPR1A,
ACVR1B,
SREBF1,
PPARG,
ZEB1,
RBMX,
BRCA1,
PBX1,
PBX2,
STAT3,
ETV5,
WNT5A,
ELK3,
CDKN2B,
NR4A2,
NAMPT,
GATA4,
NKX2-1,
ATRX,
NOTCH1,
YAP1,
ID4,
SOX9,
NRIP1,
SLC11A1,
CDK8,
CEBPD,
GSK3B,
MEOX1,
LHX2,
ETV1,
ASCL1,
CDK7,
SMARCA2,
SMARCA4,
STAT5B,
LUM,
GTF2A2,
HMGA2,
FOSB,
CEBPG,
SUB1,
NR1H2,
F2RL1,
MLLT10,
CDH13,
HDAC4,
CTBP2,
SOX8,
FOXL2,
CD81,
SUMO2,
LMO4,
RPS27A,
UBA52,
YBX1,
IGBP1,
JAG1,
PRKDC,
ELF3,
SMAD3,
PKD1,
FOXO4,
TFAM,
HSF1,
E2F1,
RUNX1,
RELB,
POU5F1,
MEF2A,
NRG1,
SP3,
HHEX,
POU3F1,
CREM,
CEBPZ,
RELA,
ACVR1,
REL,
RNASEL,
EXOSC9,
MEF2C,
GABPA,
PAX8,
SOX4,
DLX2,
PPARA,
FOXM1,
PPP3CA,
EP300,
SREBF2,
FOXO1,
HYAL2,
FOXC1,
NR1H3,
TARDBP,
FADD,
MAP2K5,
MAPK7,
TRIM28,
IKZF1,
NFATC2,
SMAD4,
SQSTM1,
MED21,
RIPK1,
HDAC1,
PKD2,
BMPR2,
CBFB,
NFYC,
CAMK1,
IL18,
TFDP1,
HES1,
NFE2L1,
LPIN1,
MEF2D,
MTF1,
NFATC4,
MORF4L2,
PRKD1,
PPP2R5B,
ANKRD1,
PCBP1,
RPS6KA1,
TEAD2,
NCOA2,
TWIST1,
NCOA1,
SMAD2,
SMAD1,
ADIRF,
USF2,
ZIC1,
HLF,
MAPK14,
HIF1A,
IFI16,
ARID4B,
DCAF6,
PLAG1,
JADE1,
NIPBL,
ATAD2,
SLC30A9,
CRTC3,
RNF111,
ASXL2,
PID1,
SETX,
MAVS,
AKNA,
PCGF5,
NLRC5,
PPARGC1B,
TMPRSS6,
CRLF3,
SIRT2,
MAML2,
AHI1,
ZNF567,
ZBTB38,
NFATC2IP,
GLIS3,
ZMIZ2,
FLCN,
LILRB1,
NCOA7,
CTCFL,
GABPB2,
OSR1,
ZNF564,
ZFPM2,
GLMP,
CKAP2,
PHIP,
ARNTL2,
KAT6B,
CSRNP3,
RTF1,
NR4A3,
HSPH1,
HDAC2,
PROX1,
CREBBP,
EZH1,
KAT2B,
DDX17,
GATA6,
SMARCC1,
ARHGEF2,
MED12,
MYDGF,
WBP2,
ZBED3,
ABHD14B,
MAML3,
ZNF462,
IFT74,
NR1H4,
CITED4,
CSRNP1,
CCNL2,
ZNF382,
UHRF1,
TCF12,
GPER1,
TEAD3,
MEIS3,
PITX2,
NPAS2,
EPAS1,
ARID3A,
CITED1,
CITED2,
PAGR1,
SSBP3,
HELZ2,
TBL1XR1,
PRKD2,
FOXP3,
PEG3,
ZNF350,
CSRNP2,
NUCKS1,
EPC1,
IKZF4,
DHX36,
HIPK2,
FZD8,
RGCC,
SOX17,
SMYD3,
EBF2,
BCL2L12,
PATZ1,
BEX1,
TAF9B,
CHD8,
SLC40A1,
HEYL,
TCF7L2,
ASH1L,
MED17,
AATF,
EHF,
GRHL1,
CHD7,
RERE,
PPARGC1A,
ASH2L,
TCF20,
ARMCX3,
TBK1,
TRPS1,
NUFIP1,
ZNF639,
KLF15,
CNOT7,
MOSPD1,
CCNL1,
AGO2,
ELF5,
CCPG1,
MKL2,
ZMIZ1,
MAFF,
MYO6,
PLAGL1,
TFR2,
HDAC5,
ZNF148,
RUVBL2,
HIF3A,
THRAP3,
KLF13,
MTF2,
PAXBP1,
HEY1,
MAFB,
KLF2,
FHOD1,
CHCHD2,
NCOA3,
CAMTA1
|
GO:0045945
|
BP
|
positive regulation of transcription from RNA polymerase III promoter
|
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase III promoter.
|
ERBB2,
AR,
ICE2,
CHD8
|
GO:0045947
|
BP
|
negative regulation of translational initiation
|
Any process that stops, prevents, or reduces the frequency, rate or extent of translational initiation.
|
TPR,
FMR1,
EIF4EBP1,
EIF4EBP2,
PAIP2,
RBM4,
EIF2AK4,
EIF2B4,
AGO2
|
GO:0045948
|
BP
|
positive regulation of translational initiation
|
Any process that activates or increases the frequency, rate or extent of translational initiation.
|
DDX3X,
POLR2D,
CDC123,
CCL5,
POLR2G,
KHDRBS1,
EIF2B5,
UHMK1,
YTHDF1
|
GO:0045950
|
BP
|
negative regulation of mitotic recombination
|
Any process that inhibits or decreases the rate of DNA recombination during mitosis.
|
MLH1
|
GO:0045953
|
BP
|
negative regulation of natural killer cell mediated cytotoxicity
|
Any process that stops, prevents, or reduces the rate of natural killer mediated cytotoxicity.
|
MICA,
LILRB1
|
GO:0045954
|
BP
|
positive regulation of natural killer cell mediated cytotoxicity
|
Any process that activates or increases the frequency, rate or extent of natural killer cell mediated cytotoxicity.
|
LAMP1,
PVR,
VAV1,
LAG3,
IL12A,
STAT5B,
CADM1
|
GO:0045955
|
BP
|
negative regulation of calcium ion-dependent exocytosis
|
Any process that stops, prevents, or reduces the frequency, rate or extent of calcium ion-dependent exocytosis.
|
NOTCH1,
TRIM9
|
GO:0045956
|
BP
|
positive regulation of calcium ion-dependent exocytosis
|
Any process that activates or increases the frequency, rate or extent of calcium ion-dependent exocytosis.
|
CACNA1G,
SYT1,
STXBP1,
ARF1,
CDK5
|
GO:0045957
|
BP
|
negative regulation of complement activation, alternative pathway
|
Any process that stops, prevents, or reduces the frequency, rate or extent of complement activation by the alternative pathway.
|
CR1
|
GO:0045959
|
BP
|
negative regulation of complement activation, classical pathway
|
Any process that stops, prevents, or reduces the frequency, rate or extent of complement activation by the classical pathway.
|
CR1
|
GO:0045963
|
BP
|
negative regulation of dopamine metabolic process
|
Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways involving dopamine.
|
COMT,
SNCA
|
GO:0045964
|
BP
|
positive regulation of dopamine metabolic process
|
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving dopamine.
|
GPR37,
MAOB,
ABAT
|
GO:0045976
|
BP
|
negative regulation of mitotic cell cycle, embryonic
|
Any process that stops, prevents or reduces the rate or extent of progression through the embryonic mitotic cell cycle.
|
CTNNB1
|
GO:0045977
|
BP
|
positive regulation of mitotic cell cycle, embryonic
|
Any process that activates or increases the frequency, rate or extent of progression through the embryonic mitotic cell cycle.
|
HES1
|
GO:0045986
|
BP
|
negative regulation of smooth muscle contraction
|
Any process that stops, prevents, or reduces the frequency, rate or extent of smooth muscle contraction.
|
ADRB2,
PTGS2
|
GO:0045987
|
BP
|
positive regulation of smooth muscle contraction
|
Any process that activates or increases the frequency, rate or extent of smooth muscle contraction.
|
ADA,
EDN1,
ITGA2,
CHRM3,
EDN2,
ADRA1D,
F2R,
ADRA1A,
PTGS2,
ADRA1B,
NMU,
NPY2R,
CTTN,
SPHK1
|
GO:0045988
|
BP
|
negative regulation of striated muscle contraction
|
Any process that stops, prevents, or reduces the frequency, rate or extent of striated muscle contraction.
|
ATP1A2
|
GO:0045994
|
BP
|
positive regulation of translational initiation by iron
|
Any process involving iron that activates or increases the rate of translational initiation.
|
TNF
|
GO:0045995
|
BP
|
regulation of embryonic development
|
Any process that modulates the frequency, rate or extent of embryonic development.
|
INSR,
CDK1,
LAMA2,
LAMA4,
LAMA3,
PHLDA2,
NIPBL,
SOX17,
NOCT
|
GO:0046005
|
BP
|
positive regulation of circadian sleep/wake cycle, REM sleep
|
Any process that activates or increases the duration or quality of rapid eye movement (REM) sleep.
|
GHRH
|
GO:0046007
|
BP
|
negative regulation of activated T cell proliferation
|
Any process that stops, prevents or reduces the rate or extent of activated T cell proliferation.
|
PRNP,
PRKAR1A,
BTN2A2,
FOXP3
|
GO:0046010
|
BP
|
positive regulation of circadian sleep/wake cycle, non-REM sleep
|
Any process that activates or increases the duration or quality of non-rapid eye movement (NREM) sleep.
|
NPY2R,
GHRL
|
GO:0046022
|
BP
|
positive regulation of transcription from RNA polymerase II promoter during mitosis
|
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter during mitosis.
|
ZNF268
|
GO:0046031
|
BP
|
ADP metabolic process
|
The chemical reactions and pathways involving ADP, adenosine 5'-diphosphate.
|
AMPD3,
BAD
|
GO:0046032
|
BP
|
ADP catabolic process
|
The chemical reactions and pathways resulting in the breakdown of ADP, adenosine 5'-diphosphate.
|
NUDT9
|
GO:0046033
|
BP
|
AMP metabolic process
|
The chemical reactions and pathways involving AMP, adenosine monophosphate.
|
AK1,
AK4,
AK3
|
GO:0046034
|
BP
|
ATP metabolic process
|
The chemical reactions and pathways involving ATP, adenosine triphosphate, a universally important coenzyme and enzyme regulator.
|
AK1,
ATP1B1,
HSPA1A,
HSPA1B,
ATP6V1B2,
AK4,
NDUFS1,
ATP1A2,
VCP,
AMPD3,
GUK1,
BAD,
MYH4
|
GO:0046037
|
BP
|
GMP metabolic process
|
The chemical reactions and pathways involving GMP, guanosine monophosphate.
|
CASK,
DLG4,
MPP1,
DLG1,
GUK1,
TJP2
|
GO:0046039
|
BP
|
GTP metabolic process
|
The chemical reactions and pathways involving GTP, guanosine triphosphate.
|
GNAI3,
RHOQ,
AK4,
AMPD3,
AK3
|
GO:0046040
|
BP
|
IMP metabolic process
|
The chemical reactions and pathways involving IMP, inosine monophosphate.
|
ADSS,
ADSSL1
|
GO:0046041
|
BP
|
ITP metabolic process
|
The chemical reactions and pathways involving ITP, inosine triphosphate.
|
AK3
|
GO:0046051
|
BP
|
UTP metabolic process
|
The chemical reactions and pathways involving UTP, uridine (5'-)triphosphate.
|
AK3
|
GO:0046054
|
BP
|
dGMP metabolic process
|
The chemical reactions and pathways involving dGMP, deoxyguanosine monophosphate (2'-deoxyguanosine 5'-phosphate).
|
GUK1
|
GO:0046058
|
BP
|
cAMP metabolic process
|
The chemical reactions and pathways involving the nucleotide cAMP (cyclic AMP, adenosine 3',5'-cyclophosphate).
|
PTH,
PTHLH
|
GO:0046060
|
BP
|
dATP metabolic process
|
The chemical reactions and pathways involving dATP, deoxyadenosine triphosphate (2'-deoxyadenosine 5'-triphosphate).
|
GUK1
|
GO:0046061
|
BP
|
dATP catabolic process
|
The chemical reactions and pathways resulting in the breakdown of dATP, deoxyadenosine triphosphate (2'-deoxyadenosine 5'-triphosphate).
|
ADA,
NUDT1,
SAMHD1
|
GO:0046068
|
BP
|
cGMP metabolic process
|
The chemical reactions and pathways involving cyclic GMP, guanosine 3',5'-phosphate.
|
PDE9A,
RORA
|
GO:0046069
|
BP
|
cGMP catabolic process
|
The chemical reactions and pathways resulting in the breakdown of cyclic GMP, guanosine 3',5'-phosphate.
|
PDE5A,
PDE9A
|
GO:0046070
|
BP
|
dGTP metabolic process
|
The chemical reactions and pathways involving dGTP, guanosine triphosphate.
|
DGUOK
|
GO:0046078
|
BP
|
dUMP metabolic process
|
The chemical reactions and pathways involving dUMP, deoxyuridine (5'-)monophosphate (2'-deoxyuridine 5'-phosphate).
|
TYMS
|
GO:0046081
|
BP
|
dUTP catabolic process
|
The chemical reactions and pathways resulting in the breakdown of dUTP, deoxyuridine (5'-)triphosphate.
|
DUT
|
GO:0046084
|
BP
|
adenine biosynthetic process
|
The chemical reactions and pathways resulting in the formation of adenine, 6-aminopurine, one of the five main bases found in nucleic acids and a component of numerous important derivatives of its corresponding ribonucleoside, adenosine.
|
PAICS
|
GO:0046085
|
BP
|
adenosine metabolic process
|
The chemical reactions and pathways involving adenosine, adenine riboside, a ribonucleoside found widely distributed in cells of every type as the free nucleoside and in combination in nucleic acids and various nucleoside coenzymes.
|
ACPP,
PTGDR
|
GO:0046086
|
BP
|
adenosine biosynthetic process
|
The chemical reactions and pathways resulting in the formation of adenosine, adenine riboside, a ribonucleoside found widely distributed in cells of every type as the free nucleoside and in combination in nucleic acids and various nucleoside coenzymes.
|
NT5E
|
GO:0046092
|
BP
|
deoxycytidine metabolic process
|
The chemical reactions and pathways involving deoxycytidine, 2-deoxyribosylcytosine, one of the four major nucleosides of DNA.
|
TK2
|
GO:0046098
|
BP
|
guanine metabolic process
|
The chemical reactions and pathways involving guanine, 2-amino-6-hydroxypurine, a purine that is one of the five main bases found in nucleic acids and a component of a number of phosphorylated guanosine derivatives whose metabolic or regulatory functions are important.
|
KDM1A
|
GO:0046101
|
BP
|
hypoxanthine biosynthetic process
|
The chemical reactions and pathways resulting in the formation of hypoxanthine, 6-hydroxy purine, an intermediate in the degradation of adenylate. Its ribonucleoside is known as inosine and its ribonucleotide as inosinate.
|
PRPS1
|
GO:0046103
|
BP
|
inosine biosynthetic process
|
The chemical reactions and pathways resulting in the formation of inosine, hypoxanthine riboside, a nucleoside found free but not in combination in nucleic acids except in the anticodons of some tRNAs.
|
ADA
|
GO:0046104
|
BP
|
thymidine metabolic process
|
The chemical reactions and pathways involving thymidine, deoxyribosylthymine thymine 2-deoxyriboside, a deoxynucleoside very widely distributed but occurring almost entirely as phosphoric esters in deoxynucleotides and deoxyribonucleic acid, DNA.
|
TK2,
TK1
|
GO:0046108
|
BP
|
uridine metabolic process
|
The chemical reactions and pathways involving uridine, uracil riboside, a ribonucleoside very widely distributed but occurring almost entirely as phosphoric esters in ribonucleotides and ribonucleic acids.
|
UPP2
|
GO:0046111
|
BP
|
xanthine biosynthetic process
|
The chemical reactions and pathways resulting in the formation of xanthine, 2,6-dihydroxypurine, a purine formed in the metabolic breakdown of guanine but not present in nucleic acids.
|
ADA
|
GO:0046121
|
BP
|
deoxyribonucleoside catabolic process
|
The chemical reactions and pathways resulting in the breakdown of any one of a family of organic molecules consisting of a purine or pyrimidine base covalently bonded to a sugar deoxyribose (a deoxyribonucleoside).
|
DERA
|
GO:0046122
|
BP
|
purine deoxyribonucleoside metabolic process
|
The chemical reactions and pathways involving any one of a family of organic molecules consisting of a purine base covalently bonded to a sugar deoxyribose (a deoxyribonucleoside).
|
DGUOK
|
GO:0046130
|
BP
|
purine ribonucleoside catabolic process
|
The chemical reactions and pathways resulting in the breakdown of any purine ribonucleoside, a nucleoside in which purine base is linked to a ribose (beta-D-ribofuranose) molecule.
|
ENPP4
|
GO:0046134
|
BP
|
pyrimidine nucleoside biosynthetic process
|
The chemical reactions and pathways resulting in the formation of one of a family of organic molecules consisting of a pyrimidine base covalently bonded to a sugar ribose (a ribonucleoside) or deoxyribose (a deoxyribonucleoside).
|
TYMS,
UMPS,
CAD,
DCTD,
DUT,
DHODH
|